There is a lot of stigma around psychedelics.Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.Topics in this episode0:00 Intro  1:07 Founding EYWA  3:53 Advice for Startup Founders in LATAM  8:51 What is Biosynthesis?  12:34 What Molecules is EYWA Focusing On?  13:35 How to Show Commercial Traction Before Regulatory Approval?  15:03 The Psychedelics Ecosystem  16:26 Scientific Data About Psychedelics  23:51 What is EYWA's Business Model?  25:49 How Does IP Shape an R&D Roadmap?  27:56 Why Use AI and Bioinformatics?  33:27 Regulatory Landscape for Psychedelics  40:14 The Investors' Perception of Psychedelics  44:17 EYWA's Most Recent Funding Round  46:14 Building Relationships with Investors  51:02 EYWA's Fundraising Plans  51:37 Recording a TV Show with Tim and Adam Draper  53:43 What's Next for EYWA  Connect with Vicky on LinkedIn https://www.linkedin.com/in/victoria-costa-paz-a83499b2/Follow EYWA on LinkedIn https://www.linkedin.com/company/eywabio/posts/?feedView=all Follow EYWA on Instagram https://www.instagram.com/eywa.bio/Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vcFollow Science VC on Instagram https://www.instagram.com/science.vcSubscribe to Science VC on YouTube https://www.youtube.com/@ScienceVCSubscribe to our Newsletter https://substack.com/@jporlovLearn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

Ver todos los episodios